Trial Search Results

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

To improve survival outcomes for patients with MDS and MPD with a nonmyeloablative allogeneic hematopoietic cell transplant.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institutes of Health (NIH)

Stanford Investigator(s):

Intervention(s):

  • Procedure: nonmyeloablative allogeneic hematopoietic cell transplant

Phase:

N/A

Eligibility


Inclusion Criteria:- Myelodysplastic Syndromes

   - Myeloproliferative Disorders

   - HLA matched donor available Exclusion Criteria:- organ dysfunction

   - HIV positive

Ages Eligible for Study

18 Years - 75 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
6507230822